MENU
TRUP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Trupanion (TRUP) Earnings Date & Reports

Trupanion Inc is a specialty insurance products provider in the United States... Show more

A.I. Advisor
published Earnings

TRUP is expected to report earnings to fall 3.76% to 20 cents per share on February 17

Trupanion TRUP Stock Earnings Reports
Q4'26
Est.
$0.20
Q3'26
Beat
by $0.05
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.04
Q4'25
Missed
by $0.03
The last earnings report on November 05 showed earnings per share of 20 cents, beating the estimate of 15 cents. With 279.97K shares outstanding, the current market capitalization sits at 1.61B.
A.I.Advisor
Nov 05, 2026

Trupanion (TRUP) Third Quarter 2026 Earnings Recap: Record Free Cash Flow and a Growing Pet Base

Key Takeaways

  • Total revenue rose 11% year over year (YoY) to $405.6 million, topping the FactSet consensus estimate of roughly $402.5 million.
  • Net income reached $9.3 million, or $0.21 per share, marking Trupanion's sixth consecutive quarter of profitability.
  • Subscription adjusted operating income (AOI) hit an all-time high of $45.4 million, with subscription adjusted operating margin improving to 15.8%.
  • Total subscription pets grew 6% YoY to 1,145,000, while average monthly retention rose to 98.38%, a seventh straight quarter of improvement.
  • Free cash flow (FCF) reached a record $28.5 million, and management narrowed its full-year 2026 guidance to the higher end of its prior range.
  • For more information about this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the additional pages available on Tickeron.
  • You can also explore Trending AI Robots to discover AI-driven trading strategies and market insights.

Earnings Context and Why It Matters

Trupanion is a leading provider of medical insurance for cats and dogs across the United States, Canada, and select European markets. Its third quarter 2026 results matter because they test whether the company can sustain its recent profitability turnaround while continuing to grow its subscriber base in a market that remains vastly underpenetrated. Coming off a strong second quarter, investors were watching retention, pet acquisition economics, and free cash flow generation. The company's ability to keep pricing aligned with double-digit veterinary inflation, while simultaneously lowering its cost to acquire each new pet, is central to its long-term margin story. These results offer a clearer read on whether Trupanion's investments in brand awareness and product flexibility are translating into durable, higher-quality growth.

Reported Results

Trupanion reported total revenue of $405.6 million for the third quarter of 2026, up 11% YoY and ahead of the roughly $402.5 million FactSet consensus. Subscription revenue grew 14% YoY to $287.9 million, while other business revenue rose 3% to $117.7 million.

The company posted net income of $9.3 million, or $0.21 per basic and diluted share, compared with $5.9 million, or $0.14 per share, in the year-ago period. Total monthly average revenue per pet climbed 8% YoY to $88.95, and total subscription pets increased 6% to 1,145,000 as of September 30.

Profitability metrics continued to strengthen. Subscription AOI (a non-GAAP measure of operating profitability that excludes certain items) reached a record $45.4 million, up 16% YoY, with a 15.8% margin. Total AOI rose 15% to $47 million. The average cost to acquire a pet fell to $279 from $290 a year earlier, reflecting improved marketing efficiency.

Management also raised its outlook. Full-year 2026 total revenue is now expected between $1.59 billion and $1.597 billion, with total AOI guided to $179 million to $182 million, implying roughly 19% growth at the midpoint.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is particularly useful for identifying trade ideas, trending stocks, breakout candidates, and emerging market opportunities far more efficiently than manual screening. Whether you are evaluating companies like Trupanion or surveying an entire sector, the AI Screener provides a structured way to surface ideas that match your criteria.

Market Reaction and Investor Sentiment

Trupanion entered this earnings report with positive momentum, having delivered a strong beat and raise in the second quarter. The third-quarter results reinforce that narrative: revenue came in above consensus, profitability extended its streak, free cash flow reached a record, and guidance was lifted. Those factors are typically viewed favorably by investors focused on the company's path toward sustained profitability.

At the same time, sentiment remains sensitive to the value proposition metric, which measures the share of subscription revenue used to pay veterinary invoices. It declined modestly to 69.7% from 70.1% a year ago, a slight headwind worth monitoring. Overall, the combination of record AOI, improving pet acquisition costs, and raised full-year guidance suggests investors received the report as evidence that Trupanion's growth and margin trajectory remain intact.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors should focus on whether Trupanion can sustain its improving unit economics. The decline in average pet acquisition cost, from $290 to $279 per pet, signals that its marketing and brand investments are becoming more efficient. Continued progress here would support both faster pet growth and stronger margins over time.

Retention will remain a critical metric. Average monthly retention rose for a seventh consecutive quarter to 98.38%, a trend that underpins the company's recurring revenue model. Sustaining high retention while rolling out new deductible and co-insurance options across North America will be an important test of product flexibility.

Veterinary inflation remains a key watch item. Because Trupanion's model prices coverage to track rising veterinary costs, persistent double-digit inflation could pressure the value proposition and member economics. The October partnership with Simon Cowell adds a notable brand-awareness catalyst aimed at reaching new pet parents earlier.

Finally, capital allocation deserves attention. The company repurchased roughly 830,000 shares for about $25 million in the quarter and ended the period with $396.8 million in cash and short-term investments against $104.5 million in debt. How management balances buybacks, growth investment, and its European expansion will help shape the next phase of the story.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations